12 S. Sortino et al.
16. Saenger, W. (1980) Cyclodextrin inclusion compounds in re-
search and industry. Angew. Chem. Int. Ed. Engl. 19, 344–362.
17. Wenz, G. (1994) Cyclodextrins as building blocks for supra-
molecular structures and functional units. Angew. Chem. Int. Ed.
Engl. 33, 803–822.
The present report can also be of biological relevance.
Actually, given the potential of CD in providing an useful
model to mimic the interactions of the drug with hydropho-
bic biological sites and by taking into account that all the
18. Uekama, K., F. Hirayama and T. Ire (1998) Cyclodextrin drug
carrier systems. Chem Rev. 98, 2045–2076.
19. Ramamurthy, V., R. G. Weiss and G. S. Hammond (1993) A
model for the influence of organized media on photochemical
reactions. Adv. Photochem. 18, 67–234.
20. Ramamurthy, V. (1991) Photochemistry in Organized and Con-
strained Media. VCH Publishers, New York.
21. Kalyanasundaram, K. (1987) Photochemistry in Microhetero-
geneous Systems. Academic Press. Orlando.
22. Monti, S., S. Sortino, G. De Guidi and G. Marconi (1998) Su-
pramolecular photochemistry of 2-(3-benzoylphenyl)propionic
acid (Ketoprofen). A study in the -cyclodextrin cavity. New J.
Chem. 22, 599–604.
23. Sortino, S., G. De Guidi, G. Marconi and S. Monti (1998) Trip-
let photochemistry of suprofen in aqueous environment and in
photoproducts formed in -CD are mediated by radical path-
ways, the obtained results represent a good step forward in
understanding the recently reported phototoxic effects dis-
played by FM. Incorporation or localization of the drug in
specific pockets of a biosubstrate with particular hydropho-
bicity and in the presence of steric constrains and specific
interactions, could lead in fact to new and more efficient
photodegradation pathways, with a significant increase in the
photoproduction of radical species.
Finally, in light of the much lower photostability of the
FM–-CD inclusion complex if compared with the free mol-
ecule, the study presented herein suggests that the use of
CD, or similar kinds of drug/carrier system, could not be the
more appropriate approach to enhance the drug solubility.
the
-cyclodextrin inclusion complex. Photochem. Photobiol.
67, 603–611.
24. Sortino, S., J. C. Scaiano, G. De Guidi and S. Monti (1999)
Effect of -cyclodextrin complexation on the photochemical and
photosensitizing properties of tolmetin: a steady state and time
resolved study. Photochem. Photobiol. 70, 549–556.
Acknowledgements Partial financial supports from MURST in the
framework of the ‘‘Programmi di Ricerca di Rilevante Interesse Na-
zionale’’ (project: Mechanisms of Photoinduced Processes in Ho-
mogeneous Media and in Complex Matrices) and from the Progetto
‘‘Proprieta` Chimico-Fisiche dei medicamenti e loro sieurezze
d’uso’’ of the ISS is gratefully acknowledged. We wish to thank Dr.
F. Vargas for sharing with us a preprint of his manuscript.
25. Jimenez, M. C., M. A. Miranda and R. Tormos (1995) Photo-
decarboxylation of 2-phenylpropionic acid in solution and in-
duced within -cyclodextrin. Tetrahedron 51, 2953–2958.
26. Monti, S., S. Sortino, S. Encinas, G. Marconi, G. De Guidi and
M. A. Miranda (1998) Photoprocesses in photosensitizing drugs
containing a benzophenone-like chromophore. In: Drugs Pho-
tochemistry and Photostability (Edited by A. Albini and E. Fa-
sani), pp. 150–161. The Royal Society of Chemistry, Cam-
bridge.
27. De Guidi, G., G. Condorelli, L. L. Costanzo, S. Giuffrida, S.
Monti, and S. Sortino (1998) Molecular mechanisms of photo-
sensitization induced by drugs on biological systems and design
of photoprotective systems. In: Drugs Photochemistry and Pho-
tostability (Edited by A. Albini and E. Fasani), pp. 194–210.
The Royal Society of Chemistry Cambridge.
REFERENCES
1. Schellhammer, P., R. Sharifi and N. Block (1995) A controlled
trial of bicalutamide versus flutamide, each in combination with
luteinizing hormone-releasing hormone analogue therapy, in pa-
tients with advanced prostate cancer. Urology 45, 745–752.
2. Ornstein, D. K. (1998) Combined finasteride and flutamide ther-
apy in men with advanced prostate cancer. Urology 48, 901–
905.
3. Mahler, C., J. Verhelst and L. Denism (1998) Clinical phar-
macokinetics of the antiandrogens and their efficacy in prostate
cancer. Clin. Pharmacokinet. 34, 405–417.
4. Leroy, D., A. Dompmartin and C. Szczurko (1996) Flutamide
photosensitivity. Photodermatol. Photoimmunol. Photomed. 12,
216–218.
5. Zabala, R., J. Gardeazabal and D. Manzano (1995) Photosen-
sibilidad por flutamida. Acta Dermosifiliogr. 86, 323–325.
6. Vilaplana, J., C. Romaguera, A. Azon and M. Lecha (1998)
Flutamide photosensitivity-residual vitiliginous lesions. Contact
Dermatitis 38, 68–70.
7. Reid, M. B. and L. M. Glode (1998) Flutamide induced lupus.
J. Urol. 159, 2098–2101.
8. Yokote, R., Y. Tokura, N. Igarashi, O. Ishikawa and Y. Miyachi
(1998) Photosensitive drug eruption induced by flutamide. Eur.
J. Dermatol. 8, 427–429.
28. De Guidi, G., G. Condorelli, S. Giuffrida, G. Puglisi and G.
Giammona (1993) Effect of -cyclodextrin complexation on the
photohemolytic activity induced by ketoprofen and naproxen
sensitization. J. Incl. Phenom. Mol. Rec. Chem. 15, 43–58.
29. Hoshino, T. H., K. Ishida, T. Irie, F. Hirayama and M. Yamasaki
(1988) Reduction of photohemolytic activity of benoxaprofen
by -cyclodextrin complexation. J. Incl. Phenom. 6, 415–423.
30. Adel, M. A., A. S. Geneidi, R. Ali Shoukri and I. Saad (1997)
In vitro evaluation of flutamide-carrier systems. Pharmazie 52,
373–375.
31. Uekama, K., F. Hirayama and T. Irie (1998) Cyclodextrin drug
carrier systems. Chem. Rev. 98, 2045–2076.
32. De Guidi, G., R. Chillemi, L. L. Costanzo, S. Giuffrida, S. Sor-
tino and G. Condorelli (1994) Molecular mechanism of drug
photosensitization. Part 5. Photohemolysis sensitized by supro-
fen. J. Photochem. Photobiol. B: Biol. 23, 125–133.
9. Borroni, G., V. Brazzelli, F. Baldini, F. Borghini, M. R. Gav-
iglio, B. Beltrami and G. Nolli (1998) Flutamide-induced pseu-
doporphyria. Br. J. Dermatol. 138, 711–712.
10. Vargas, F., C. Rivas, H. Mendez, A. Fuentes, G. Fraile and M.
Velasquez Photochemistry and phototoxicity studies of fluta-
mide, a phototoxic anti-cancer drug. J. Photochem. Photobiol.
B: Biol. (In press)
33. Hyperchem package, Hypercube Inc., Waterloo Canada, 1996.
34. Hurley, R. and A. C. Testa (1966) Photochemical n–* exci-
tation of nitrobenzene. J. Am. Chem. Soc. 88, 4330–4332.
35. Barltropp, J. A. and N. J. Bunce (1968) Organic photochemistry.
Part VIII. The photochemical reduction of nitrocompounds. J.
Chem. Soc. 1467–1474.
36. Levy, N. and M. D. Cohen (1979) Photoreduction of 4-cyano-
1-nitrobenzene in propan-2-ol. J. Chem. Soc. Perkin Trans. II
553–558.
11. Bortolus, P. and S. Monti (1996) Photochemistry in cyclodextrin
cavities. Adv. Photochem. 21, 1–133.
12. Bender, M. L. and M. Komiyana (1978) Cyclodextrin Chemis-
try. Springer, Berlin.
13. Szejtli, J. and T. Osa (1996) Cyclodextrins Comprensive Supra-
molecular Chemistry. Elsevier, New York.
37. Bosca`, F., M. A. Miranda, G. Serrano and F. Vargas (1998)
Photochemistry and photobiological properties of dicloran, a
prostharvest fungicide with photosensitizing side effects. Pho-
tochem. Photobiol. 67, 532–537.
14. Balzani, V. and L. De Cola (1992) Supramolecular Chemistry.
Kluwer, Dordrecht.
38. Gilbert, A. and J. Baggot (1991) Essentials of Molecular Pho-
tochemistry. Blackwell Scientific, London.
15. Sztejtli, J. (1982) Cyclodextrins and their Inclusion Complexes.
Akademiai Kiado, Budapest.
39. N. J. Turro (1978) Modern Molecular Photochemistry. Benja-
min/Cummings Publishing, Menlo Park.